A Comparison of Pain between Parkinson's Disease and Multiple System Atrophy: A Clinical Cross-Sectional Survey

Pain Research & Management : the Journal of the Canadian Pain Society = Journal De La Société Canadienne Pour Le Traitement De La Douleur
He-Yang YouXiao-Ling Ding

Abstract

Pain is frequent in Parkinson's disease (PD) and Parkinson-plus syndrome. This study aimed to assess the prevalence, characteristics, therapy (especially the effect of dopaminergic therapy), and associated symptoms of pain in Parkinson's disease and multiple system atrophy (MSA) patients. Seventy-one PD patients, sixty-five MSA patients, and forty age-matched healthy controls were enrolled and evaluated by using the German pain questionnaire and visual analogue scale (VAS). In addition, the influence of pain in PD patients on anxiety, depression, and the quality of life was assessed with the Hospital Anxiety and Depression Scale (HADS) and Parkinson's Disease Questionnaire (PDQ-39). Compared to that of the healthy controls, the PD and MSA patients had a significantly higher presence of pain (P < 0.01, P < 0.01). PD patients had a higher presence of pain than MSA patients (P=0.007). No difference in VAS scores was observed between the PD and MSA patients (P=0.148). A total of 21 PD patients (42.85%) with pain and 13 MSA patients (43.33%) with pain received treatment. A total of 13 PD patients with pain and 6 MSA patients with pain had an improved pain intensity after using dopaminergic medication. The differences in the disease ...Continue Reading

References

Jul 23, 2008·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·M KubotaN Ueta
Dec 23, 2008·Pain·A G BeiskeE Svensson
May 5, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Angelika Nebe, Georg Ebersbach
Aug 12, 2009·Journal of Neurology·Carlo ColosimoUNKNOWN PRIAMO STUDY GROUP
Dec 22, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Georg GoebelChristoph Scherfler
Jan 11, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Martijn P G BroenWim E J Weber
Jan 19, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·David J Brooks
Sep 21, 2013·Parkinsonism & Related Disorders·Antoniya Todorova, K Ray Chaudhuri
Oct 1, 2013·Neuroscience Letters·Armando PerrottaGiorgio Sandrini
Apr 2, 2014·Parkinsonism & Related Disorders·Jean PellapratChristine Brefel-Courbon
Apr 16, 2015·Brain and Behavior·Lewis Kass-IliyyaMonty A Silverdale
Mar 1, 2017·Journal of Neurology·Carsten BuhmannUlrike Bingel
Oct 17, 2017·Progress in Neuro-psychopharmacology & Biological Psychiatry·Pierre J Blanchet, Christine Brefel-Courbon
Nov 17, 2017·Human Brain Mapping·Alessandro TessitoreFabrizio Esposito
Dec 20, 2017·Parkinsonism & Related Disorders·F Ory-MagneC Brefel-Courbon
Feb 6, 2018·Parkinsonism & Related Disorders·Simon SungAndrew H Evans

❮ Previous
Next ❯

Citations

Mar 7, 2021·Mayo Clinic Proceedings·Elizabeth A Coon, J Eric Ahlskog

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.